The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPRP.L Regulatory News (PRP)

  • There is currently no data for PRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

15 Apr 2020 07:00

RNS Number : 6443J
Prime People PLC
15 April 2020
 

 

15 April 2020

 

Prime People plc

("Prime People" or the "Company")

 

COVID-19 Update

 

Prime People (AIM: PRP), the global specialist recruitment business for professional and technical staff working in the Real Estate & Built Environment, Energy & Environmental and Technology, Digital & Data Analytics sectors, announces the following update on trading, in light of COVID-19.

 

The health and safety of our employees, clients and candidates is of paramount importance to us. The majority of our global workforce are currently working from home. Our cloud-based platforms have allowed full business continuity and our people have been able to service clients throughout this unpredictable period.

 

As a direct result of COVID-19, we have now experienced a significant reduction in demand across our businesses with the impact varying considerably by location and sector. We have taken early action to implement a range of measures to protect our business from the financial impact of COVID-19. These include:

 

· Managing our staff costs through furlough, reductions in headcount, reduced hours and reductions in remuneration primarily in the UK. As at the date of this announcement, approximately 40% of our UK workforce are on furlough;

· Ensuring all relevant available governmental employment protection schemes are utilised for relevant employees in our international locations;

· Minimising discretionary spend and driving reductions in all operational expenditure to align with anticipated levels of business;

· Stalling planned capital expenditure and organic and non-organic growth plans; and

· Rigorous cash flow management including taking action to reduce cash outflow by the deferral of tax payments to tax authorities, where available.

 

Our present focus is on cash management and matching expenditure to likely levels of business, and implementing certain measures to ensure that we are in a position to accelerate activity when markets improve. With that in mind, in order to strengthen the balance sheet and aid liquidity, the Board does not anticipate paying a final dividend for the year ending 31 March 2020. The Board remains committed to paying progressive dividends as soon as appropriate and when there is better clarity on the financial consequences of COVID-19.

 

Peter Moore, Chief Executive Officer, commented:

 

"I would like to thank our team for their unfailing support, understanding, hard work and resilience in unprecedented times. Our historic investments in technology have meant that we are able to continue to work and communicate effectively with our clients and candidates remotely. The Group has a very experienced management team and expects that it will be in a solid position to take rapid advantage of market opportunities when they materialise".

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please contact: 

 

Prime People

Robert Macdonald, Executive Chairman

020 7318 1785

Donka Zaneva-Todorinski, Finance Director

Cenkos Securities plc

020 7397 8900

Katy Birkin/Nick Wells/Harry Hargreaves

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKQBKOBKDCQD
Date   Source Headline
15th Feb 20199:32 amRNSTransaction in Own Shares and PDMR Shareholding
14th Feb 20193:24 pmRNSTransaction in Own Shares and PDMR Shareholding
2nd Jan 201910:20 amRNSDirector/PDMR Shareholding
27th Nov 20182:30 pmRNSExercise of Options
19th Nov 201812:00 pmRNSHalf-year Report
25th Sep 20181:05 pmRNSTransaction in Own Shares
19th Jul 20181:03 pmRNSResult of AGM
6th Jul 201812:00 pmRNSReplacement - Director/PDMR Shareholding
29th Jun 20188:45 amRNSDirector/PDMR Shareholding
22nd Jun 20187:00 amRNSFinal Results
2nd May 20183:02 pmRNSTrading Update and Notice of Results
19th Feb 20183:14 pmRNSTransaction in Own Shares
8th Feb 201811:47 amRNSDirector/PDMR Shareholding
9th Jan 201810:15 amRNSExercise of Options
9th Jan 201810:15 amRNSExercise of Options
12th Dec 201710:49 amRNSTransaction in Own Shares
27th Nov 201712:05 pmRNSExercise of Options
24th Nov 201710:00 amRNSDirector/PDMR Shareholding
21st Nov 20177:00 amRNSTransaction in Own Shares
9th Nov 20177:01 amRNSIntention to purchase own shares
9th Nov 20177:00 amRNSHalf-year Report
18th Oct 20171:37 pmRNSTrading Update and Notice of Results
11th Oct 20178:38 amRNSAcquisition
24th Jul 20173:11 pmRNSResult of AGM
22nd Jun 20177:00 amRNSFinal Results & Notice of AGM
13th Apr 20179:12 amRNSShare Buy Back
21st Mar 20179:34 amRNSShare Buy Back
15th Mar 201711:35 amRNSExercise of Options
7th Mar 20174:50 pmRNSExercise of Options & Share Buy Back
23rd Feb 20177:00 amRNSExercise of Options
13th Jan 201712:01 pmRNSExercise of Options
20th Dec 20165:48 pmRNSTransaction in Own Shares
2nd Dec 20164:06 pmRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSHalf-year Report
6th Oct 20162:00 pmRNSTrading Statement
20th Sep 201612:40 pmRNSDirector/PDMR Shareholding
20th Sep 201612:29 pmRNSExercise of Options
1st Sep 20165:07 pmRNSDirector/PDMR Shareholding
31st Aug 20163:21 pmRNSExercise of Options
17th Aug 20162:12 pmRNSExercise of Options and Share Buy Back
10th Aug 201611:40 amRNSExercise of Options
3rd Aug 20161:06 pmRNSPDMR and Transaction in Own Shares
3rd Aug 201610:21 amRNSPDMR and Transaction in Own Shares
20th Jul 201612:55 pmRNSResult of AGM
20th Jul 201612:48 pmRNSDirector/PDMR Shareholding
30th Jun 20164:58 pmRNSTransaction in Own Shares
23rd Jun 20167:00 amRNSFinal Results
31st Mar 20165:15 pmRNSDirector/PDMR Shareholding
15th Mar 20167:00 amRNSDirector/PDMR Shareholding
4th Mar 20163:58 pmRNSInterim Dividend

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.